The Ovarian Cancer Symposium aims to provide a platform to bring together leading Australian researchers, clinicians and industry representatives for an open and inclusive discussion on the latest developments and advances in the field of ovarian cancer treatment and research.
Symposium for:
Gynaecological Oncologists
Medical Oncologists
Researchers
Oncologists in training
Gynaecological Nurse Consultants
Our advisory committee consists of Professor David Bowtell, Professor Anna DeFazio AM, Dr Dale Garsed, Dr Niveditha Rajadevan, Dr. Vanessa Alford (OCA) and Sue Hegarty (OCA).
Dr Denarda Dangaj Laniti (Lausanne, Switzerland)
Group leader, Tumor Microenvironment and Biomarker Discovery Laboratory, Department of Oncology, UNIL CHUV Lausanne Branch of Ludwig Institute for Cancer Research Heterogeneity and Immunobiology of High-Grade Serous Ovarian Cancer
A/Prof Kelly Bolton, MD PhD (Washington, US)
Assistant Professor, Division of Oncology, Washington University Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes
Prof David Bowtell
Prof Alison Brand
Prof Clare Scott
Dr George Au-Yeung
Dr Monique Topp
A/Prof Bo Gao
Dr Nicola Meagher
Hayley Russell (OCA)
Dr Yeh Chen Lee
Dr Michael Burling
Dr Michelle Harrison
A/Prof Lyndal Anderson
Prof Anna DeFazio AM
This one-day event was funded by AstraZeneca and GSK.
Watch the recorded presentations from the 2023 Symposium below
Ovarian Cancer Australia acknowledges the Traditional Owners of the land where our office is located, the Wurundjeri people of the Kulin Nation and we pay our respects to Elders past and present.